Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 536

1.

Morbidity in schistosomiasis: an update.

Vennervald BJ, Dunne DW.

Curr Opin Infect Dis. 2004 Oct;17(5):439-47. Review.

PMID:
15353964
2.

Immunology of human schistosomiasis: off the beaten path.

Secor WE.

Parasite Immunol. 2005 Jul-Aug;27(7-8):309-16. Review.

3.

Schistosome transcriptomes: new insights into the parasite and schistosomiasis.

Hu W, Brindley PJ, McManus DP, Feng Z, Han ZG.

Trends Mol Med. 2004 May;10(5):217-25. Review.

PMID:
15121048
4.

The global status of schistosomiasis and its control.

Chitsulo L, Engels D, Montresor A, Savioli L.

Acta Trop. 2000 Oct 23;77(1):41-51.

PMID:
10996119
5.

The unacknowledged impact of chronic schistosomiasis.

King CH, Dangerfield-Cha M.

Chronic Illn. 2008 Mar;4(1):65-79. doi: 10.1177/1742395307084407. Review.

PMID:
18322031
6.

Recent advances in Schistosoma genomics.

MourĂ£o MM, Grunau C, LoVerde PT, Jones MK, Oliveira G.

Parasite Immunol. 2012 Feb-Mar;34(2-3):151-62. doi: 10.1111/j.1365-3024.2011.01349.x. Review.

7.

Uncertainties in the epidemiology and control of schistosomiasis.

Gryseels B.

Am J Trop Med Hyg. 1996 Nov;55(5 Suppl):103-8. Review.

PMID:
8940962
8.

Schistosome glycans and innate immunity.

Hokke CH, Yazdanbakhsh M.

Parasite Immunol. 2005 Jul-Aug;27(7-8):257-64. Review.

9.

[Genetic predisposition to bilharziasis in humans: research methods and application to the study of Schistosoma mansoni infection].

Abel L, Marquet S, Chevillard C, elWali NE, Hillaire D, Dessein A.

J Soc Biol. 2000;194(1):15-8. Review. French.

PMID:
11107544
10.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
11.

Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection.

Caldas IR, Campi-Azevedo AC, Oliveira LF, Silveira AM, Oliveira RC, Gazzinelli G.

Acta Trop. 2008 Nov-Dec;108(2-3):109-17. doi: 10.1016/j.actatropica.2008.05.027. Epub 2008 Jun 5. Review.

PMID:
18577364
12.

Implementation of human schistosomiasis control: Challenges and prospects.

Fenwick A, Rollinson D, Southgate V.

Adv Parasitol. 2006;61:567-622. Review.

PMID:
16735173
13.

Schistosomiasis: host-pathogen biology.

Warren KS.

Rev Infect Dis. 1982 Jul-Aug;4(4):771-5. Review.

PMID:
6750744
14.

Schistosome-induced pathology is exacerbated and Th2 polarization is enhanced during pregnancy.

Farah IO, Langoi D, Nyaundi J, Hau J.

In Vivo. 2007 Jul-Aug;21(4):599-602.

15.

The role of somatostatin in schistosomiasis: a basis for immunomodulation in host-parasite interactions?

Chatterjee S, Van Marck E.

Trop Med Int Health. 2001 Aug;6(8):578-81. Review.

16.
17.

Hepatic schistosomiasis.

Bica I, Hamer DH, Stadecker MJ.

Infect Dis Clin North Am. 2000 Sep;14(3):583-604, viii. Review.

PMID:
10987111
18.

Schistosome infections in humans: perspectives and recent findings. NIH conference.

Nash TE, Cheever AW, Ottesen EA, Cook JA.

Ann Intern Med. 1982 Nov;97(5):740-54. Review.

PMID:
6753683
19.

Genetic epidemiology of human schistosomiasis in Brazil.

Bethony JM, Quinnell RJ.

Acta Trop. 2008 Nov-Dec;108(2-3):166-74. doi: 10.1016/j.actatropica.2007.11.008. Epub 2007 Dec 8. Review.

PMID:
18207118
20.

The impact of chemotherapy on morbidity due to schistosomiasis.

Richter J.

Acta Trop. 2003 May;86(2-3):161-83. Review.

PMID:
12745135

Supplemental Content

Support Center